logo
Burnout is at a 10-year high for U.S. workers

Burnout is at a 10-year high for U.S. workers

The Hill3 days ago

If you feel as though you've been hearing your colleagues, professional acquaintances, family or friends talk about burnout more than usual, you're not imagining it.
According to a recent report by Glassdoor, burnout among U.S. professionals has escalated to unprecedented highs, with burnout mentions in employee reviews increasing 32 percent year-on-year as of Q1 2025.
In fact, mentions of burnout have increased by 50 percent since Q4 2019, just before the Covid-19 pandemic began and irrevocably changed the world of work as we knew it. This marks the highest rate since data collection began in 2016.
While the term 'burnout' has become an all-encompassing phrase for everything from stress to lack of motivation, the World Health Organization describes burnout as a 'syndrome conceptualized as resulting from chronic workplace stress that has not been successfully managed.'
The WHO characterizes burnout via 'three dimensions'. These include feelings of energy depletion or exhaustion; increased mental distance from one's job, or feelings of negativism or cynicism related to one's job; and reduced professional efficacy.
It stressed that 'burnout refers specifically to phenomena in the occupational context and should not be applied to describe experiences in other areas of life.'
However, it's hardly surprising that employees who are experiencing burnout are seeing the repercussions of its effects in other areas of their lives.
The Glassdoor report also identified that burnout can manifest as decreased morale and diminished perceptions of career opportunities (down 21 percent), diversity and inclusion (down 17 percent), work-life balance (down 34 percent), and compensation and benefits (down 15 percent).
Additionally, the study found that employees who reference burnout tend to rate their employers significantly lower, averaging 2.68 out of 5, compared to a 3.61 average among those who don't mention burnout.
Glassdoor's Lead Economist, Daniel Zhao, describes burnout as a 'slow-burn problem' that can erode the overall employee experience, even among those who are otherwise content with their workplace.
'As businesses trim budgets and headcounts, employees and managers alike are being asked to do more with less,' said Zhao. 'That's a recipe for burnout as workers are stretched increasingly thin without an end in sight.'
He added: 'Employees who rate their employer 5 stars out of 5 are the least likely to apply to new jobs, but if they mention burnout in their reviews, their turnover intentions increase by 58 percent. Similarly, for an employee who rates their employer 4 stars, their turnover intentions rise 66 percent.'
And it's not just employees that are feeling the heat. Burnout imposed a significant financial burden on employers too. A study published in the American Journal of Preventive Medicine estimates that burnout costs employers between $4,000 and $21,000 per employee annually. For a company with 1,000 employees, this translates to an estimated $5.04 million in annual costs.
While restructuring in the name of efficiency is one way to trim headcount, a negative work environment can also have a direct impact on talent retention.
In fact, a survey by Isolved found that nearly 80 percent of employees have experienced burnout in the last year, resulting in lower engagement, reduced productising and an overwhelming feeling of restlessness that prompted 72 percent of existing employees to consider changing jobs within the next year.
So how can employers address burnout and create meaningful solutions for their employees? While some companies have implemented stress-reduction programs and are giving staff access to mental health resources, focusing on individual responsibility doesn't work in the long term.
Instead, implementing organizational changes that promote work-life balance, such as flexible working hours, four-day workweeks, childcare subsidies, and support for family care are what workers really crave.
So what can you do if you find yourself burnt out and wondering what to do, or where to go next? Seeking out a company culture that prioritizes employee wellbeing is paramount in mitigating burnout and its associated costs and if you're navigating a job hunt, The Hill's Job Board is the perfect place to focus your search.Updated daily with a range of roles in policy, communications, and related fields, it's an extremely valuable resource. Bookmark the link below, and visit regularly to stay up to date.
Ready to find a new role? Browse thousands of jobs on The Hill Job Board

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19
Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19

Business Insider

timean hour ago

  • Business Insider

Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19

Moderna (MRNA) announced that the U.S. Food and Drug Administration, FDA, has approved mNEXSPIKE, a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention. 'The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,' said Stephane Bancel, Chief Executive Officer of Moderna. 'COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health.' Confident Investing Starts Here:

FDA approves Moderna's new lower-dose Covid-19 vaccine
FDA approves Moderna's new lower-dose Covid-19 vaccine

CNBC

time6 hours ago

  • CNBC

FDA approves Moderna's new lower-dose Covid-19 vaccine

The U.S. approved a new Covid-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current Covid-19 vaccine, Spikevax — by refining its immune target. The approval "adds an important new tool to help protect people at high risk of severe disease from Covid-19," Stephane Bancel, Moderna's CEO, said in a statement Saturday. The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus. That's the same limit that the FDA set in licensing another Covid-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled Covid-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials. Moderna's existing vaccine doesn't face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall. The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said. The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results.

New COVID-19 variant detected in Washington
New COVID-19 variant detected in Washington

Yahoo

time10 hours ago

  • Yahoo

New COVID-19 variant detected in Washington

A new variant of COVID-19 has been detected in Washington. According to the Washington State Department of Health, a case was detected in a passenger at the Seattle-Tacoma International Airport. It was discovered during a voluntary nasal swab through the CDC's Traveler-based Genomic Surveillance program. The strain is called NB 1.8.1, and the World Health Organization (WHO) says it's a 'variant under monitoring.' It's been detected in 22 countries so far. The WHO says this strain's frequency has quadrupled since April – but it doesn't appear to be more dangerous than other variants. It's listed as 'low risk.' According to the Department of Health's website, COVID-19 is currently responsible for about 0.5% of hospital visits in Washington. Just shy of 400 people have died from COVID-19 in Washington through May, which is down from 897 during the same period in 2024.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store